跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIX-01294
首页
药物
BIX-01294
BIX-01294
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for promoting target cells to differentiate into nerve cells
CN 117887659 A
申请人: YUNNAN JICI REGENERATIVE MEDICINE RES INSTITUTE CO LTD
优先权: 2018
CN
修饰BIX-01294的金纳米星制备方法及其应用
CN 113425851 B
申请人: 南京市儿童医院
优先权: 2021
CN
Application of BIX-01294 in preparation of drugs for treating acute kidney injury related diseases
CN 113730416 A
申请人: NANJING CHILDRENS HOSPITAL
优先权: 2021
CN
IMMUNE ESCAPE MODULATING COMPOUNDS IN CANCER TREATMENT
WO 2026135601 A1
申请人: DOKUZ EYLUL UNIV REKTORLUGU STRATEJI GELIS DAI BASK
优先权: 2024
WO
NK cell in-vitro differentiation and amplification method and application thereof
CN 122146601 A
申请人: BEIJING DITAN HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2026
CN
Application of histone methyltransferase inhibitor BIX-01294 in preparation of medicine for treating alveolar echinococcosis
CN 121971450 A
申请人: FIRST TEACHING HOSPITAL XINJIANG MEDICAL UNIV
优先权: 2026
CN
药物
反馈